Capital A Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-28
Closed -$1.71K 472
2025
Q1
$1.71K Buy
28
+11
+65% +$641 ﹤0.01% 485
2024
Q4
$962 Buy
+17
New +$950 ﹤0.01% 565

Other funds holding BMY

Capital A Wealth Management's BMY Position: Q2 2025 in Review

Capital A Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 28 shares — an estimated $1.71K sold.

Capital A Wealth Management first reported a position in BMY in Q4 2024 and held it in 2 quarters. The position peaked at $1.71K in Q1 2025. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Capital A Wealth Management reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • Capital A Wealth Management sold 28 Bristol-Myers Squibb shares in Q2 2025, an estimated $1.71K.
  • Capital A Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 2 quarters.
  • Capital A Wealth Management's Bristol-Myers Squibb position peaked at $1.71K in Q1 2025.
  • 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Capital A Wealth Management's 13F filing for Q2 2025, filed 26 Sep 2025.